{"brief_title": "A Study Of A New Medicine (GW597599B) For The Treatment Of Major Depressive Disorder", "brief_summary": "A Placebo Controlled Study Evaluating Efficacy And Safety of Medication In Patients With Major Depressive Disorder (MDD)", "condition": "Depressive Disorder, Major", "intervention_type": "Drug", "intervention_name": "paroxetine", "other_name": "GW597599B", "criteria": "Inclusion Criteria: - Patients meet the diagnosis of Major Depressive Disorder (MDD). Exclusion Criteria: - Patients with a primary diagnosis other than MDD. - Patients with a history of schizophrenia, schizoaffective disorders, seizure disorders or bipolar affective disorder. - Patients receiving formal psychotherapy or cognitive/behavioral therapy concurrently or in the 12 weeks prior to screening visit. - Patient is actively suicidal. - Patients who have a history of migraine headaches.", "gender": "All", "minimum_age": "18 Years", "maximum_age": "65 Years", "healthy_volunteers": "No", "id": "NCT00048204.xml"}